middle.news
PainChek Unlocks US $3bn RTM Market with FDA Clearance – What’s Next?
9:18am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
PainChek Unlocks US $3bn RTM Market with FDA Clearance – What’s Next?
9:18am on Friday 30th of January, 2026 AEDT
Key Points
FDA clearance confirms PainChek device qualifies for US RTM reimbursement
US RTM market projected to reach US $3bn annually by 2030
115,000+ global contracted licences with 14.6% year-on-year growth
Strong US sales pipeline and new customer agreements in skilled nursing facilities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PAINCHEK (ASX:PCK)
OPEN ARTICLE